کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
9901426 1545420 2005 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوتکنولوژی یا زیست‌فناوری
پیش نمایش صفحه اول مقاله
Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET
چکیده انگلیسی
In addition to improving drug solubilization, cyclodextrins (CDs) also affect the biological behavior of the included compound. We evaluated the effects of two natural CDs β-CD and γ-CD, and six β-CD derivatives, Dimeb, Trimeb, SBb, 2-HP, 6AD, and 6 MTU on the biological behavior of 99mTcN-NOET, a technetium-99m-labeled, lipophilic compound readily detectable through radioactivity assessment. Determination of CDs' affinities for 99mTcN-NOET indicated that the cavity size of γ-CD was not suitable for 99mTcN-NOET inclusion, and that β-CD derivatization mostly resulted in decreased CDs affinities for 99mTcN-NOET to various extents compared with the natural β-CD. In vitro and ex vivo experiments performed on newborn rat cardiomyocytes and isolated perfused rat hearts, respectively, showed 1.7- and 2.3-fold maximal differences in 99mTcN-NOET cellular and tissue activities. Regression analyzes indicated no significant correlation between these observed biological differences and the affinities of the eight CDs tested for 99mTcN-NOET or for cellular membranes. In conclusion, CD derivatization often resulted in impaired affinity of the derivatives for the lipophilic compound 99mTcN-NOET. Moreover, the in vitro and ex vivo biological behavior of 99mTcN-NOET was greatly affected depending on the CD used for inclusion of the tracer.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 61, Issues 1–2, September 2005, Pages 40-49
نویسندگان
, , , , , , , , ,